Chemokines and chemokine receptors in pulmonary diseases

Current Opinion in Investigational Drugs

Volumn 1, Issue 3, 2000, Pages 314-320

  Sadikot, R T ^a   Christman, J W ^a   Blackwell, T S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; EOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MET RANTES; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; RANTES; UNCLASSIFIED DRUG;

ASTHMA; CHEMOTAXIS; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG TARGETING; HUMAN; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; NONHUMAN; OCCUPATIONAL LUNG DISEASE; PNEUMONIA; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW;

ANIMALS; CHEMOKINES; HUMANS; LUNG DISEASES; RECEPTORS, CHEMOKINE;

EID: 0033693642     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Neutrophil-activating peptide/interleukin 8, a novel cytokine that activates neutrophils
2. The biology of chemokines and their receptors
3. Human chemokines: An update
4. Chemokines-chemotactic cytokines that mediate inflammation
5. Chemokines
6. Human chemokines: An update
7. Interleukin 8 and related chemotactic cytokines - CXC and CC chemokines
8. Lymphotactin: A cytokine that represents a new class of chemokine
9. A new class of membrane bound chemokine with a CX3C motif
10. A burgeoning family of biological mediators: Chemokines and chemokine receptors
11. The role of nuclear factor kappa-B in pulmonary diseases
12. Chemokine receptors: Gateways to inflammation and infection
13. Structure and functional expression of a human interleukin-8 receptor
14. Characterization of two high affinity human interleukin-8 receptors
15. Neutrophil receptors for interleukin-8 and related CXC chemokines
16. Chemokine and leukocyte trafficking
17. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor
18. Endothelial cell binding of NAP-1/IL-8 role in neutrophil emigration
19. The IP-10 chemokine binds to a specific heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
20. Pathophysiology of pneumonia
21. Recombinant cytokines and pulmonary host defense
22. Properties of the novel proinflammatory supergene intercrine cytokine family
23. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/II-8
24. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia
25. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteriodes infection
26. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice
27. Neutophil and B cell expansion in mice that lack the murine IL-8 receptor homolog
28. IL-8 enhances nonoxidative intracellular killing of M. fortuitum by human granulocytes
29. Expression and regulation of chemokines in bacterial pneumonia
30. Chemokines in lung injury
31. Chemokines: Function, regulation and alteration of inflammatory responses
32. Chemokine signalling in inflammation
33. Interleukin-8 and development of adult respiratory syndrome in at risk patient groups
34. IL-8 in the BAL fluid from patients with ARDS
35. Elevated levels of NAP-1/IL-8 are present in the airspaces of patients with ARDS and are associated with increased mortality
36. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis
37. CXC chemokines and angiogenesis
38. The role of CXC chemokines in the regulation of angiogenesis
39. Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma
40. Gro β, a CXC chemokine is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice
41. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung
42. Interferon γ inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
43. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8
44. Precapillary systemic pulmonary anastomoses
45. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin
46. Effect of murine gamma interferon on cellular responses to bleomycin in mice
47. The CXC chemokines IL-8 and IP-10 regulate angiogenic activity in idiopathic pulmonary fibrosis
48. CCL chemokines and asthma
49. The role of eosinophils and neutrophils in inflammation
50. Cytokine RANTES releases by thrombin stimulated platelet is a potent attractant for human eosinophils
51. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3
52. The coordinated expression of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
53. Eosinophil chemotactic chemokine (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3, and MCP-4 and CC chemokine receptor 3 expression in bronchial biopsies from atopic and non-atopic asthmatics
54. Eotaxin and impaired lung function in asthma
55. Th1 and Th2 type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
56. Chemokine receptors and their antagonist in allergic lung disease
57. Chemokines and chemokine receptors: Their role in allergic airway diseases
58. α-Quartz -induced chemokine expression by rat lung epithelial cells
59. Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-α-induced oxidant stress
60. Chemokines as molecular targets for therapeutic intervention
61. Strategies to interfere with the chemokine network in disease
62. Essential involvement of interleukin-8 in the acute inflammation
63. Interleukin-8 antagonist generated by N-terminal modification
64. Identification of a potent selective non-peptide CXCR2 antagonist that inhibits interleukin-8 induced neutrophil migration
65. A small molecule non-peptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity